Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 85.85
-0.75 (-0.87%)
Oct 21, 2026, 2:45 PM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 25.29 billion as of October 20, 2026. It is the 4,851st most valuable company in the world and the 239th biggest in Hong Kong. Its market cap has increased by 34.56% in one year.
Market Cap
25.29B
Enterprise Value
22.37B
Revenue
963.56M
Global Rank
Country Rank
#239 Hong Kong
PE Ratio
27.64
ChartMarket Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has increased from 18.43B to 25.29B, an increase of 37.25%. That is a compound annual growth rate of 6.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 25.29B | 60.62% |
| Dec 31, 2025 | 15.75B | 84.90% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
| Jul 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocytogen Pharmaceuticals (Beijing) | 39.34B |
| 3SBio | 36.06B |
| Shanghai Junshi Biosciences | 31.16B |
| Shanghai Henlius Biotech | 28.00B |
| InnoCare Pharma | 25.93B |
| InSilico Medicine Cayman TopCo | 22.52B |
| Zai Lab | 20.43B |
| Duality Biotherapeutics | 15.39B |